Hepatitis E virus (HEV) is an etiological agent of acute hepatitis
E, a self-limiting disease prevalent in developing countries.
HEV can cause fulminant hepatic failure with high mortality
rates in pregnant women, and genotype 3 is reported to
trigger chronic hepatitis in immunocompromised individuals
worldwide. Screening of plant extracts for compounds with
potential anti-HEV effects led to the identification of a 70%
ethanol extract of Lysimachia mauritiana (LME) that interferes
with replication of the swine HEV genotype 3 replicon.
Furthermore, LME significantly inhibited replication of HEV
genotype 3 and expression of HEV ORF2 in infected cells
without exerting cytotoxic effects. Collectively, our findings
demonstrate the potential utility of LME in the development
of novel antiviral drugs against HEV infection.
Citations
Citations to this article as recorded by
Host-targeting antivirals for chronic viral infections of the liver Nicola Frericks, Mara Klöhn, Frauke Lange, Lilli Pottkämper, Arnaud Carpentier, Eike Steinmann Antiviral Research.2025; 234: 106062. CrossRef
Seedling Growth of Lysimachia mauritiana Lam. by Cell Size and Nutrient Solution Concentration Eun Ji Choi, Jun Young Kim, Gyeong Ho Jang, Soo Hoon Kim, Sang Im Oh, Hong Min Koh, SiU Hong, Mijeong Yoon, Chung Ho Ko Flower Research Journal.2024; 32(2): 103. CrossRef
Lysimachia mauritiana Lam. Extract Alleviates Airway Inflammation Induced by Particulate Matter Plus Diesel Exhaust Particles in Mice Yoon-Young Sung, Seung-Hyung Kim, Won-Kyung Yang, Heung Joo Yuk, Mi-Sun Kim, Dong-Seon Kim Nutrients.2024; 16(21): 3732. CrossRef
Hotspots and trends in global antiviral herbal basic research: A visualization analysis Liangyu Hu, Chunying Wang, Yang Zhang European Journal of Integrative Medicine.2024; 72: 102419. CrossRef
HPLC Analysis of Polyphenolic Compounds in Lysimachia nummularia L. and Comparative Determination of Antioxidant Capacity Felicia Suciu, Iuliana Stoicescu, Elena Lupu, Adina Musuc, Antoanela Popescu, Magdalena Mititelu, Adrian Roșca, Denisa-Elena Dumitrescu, Florin Badea, Aureliana Caraiane, Victoria Badea Applied Sciences.2023; 13(4): 2159. CrossRef
Hepatitis E Virus Infection: Circulation, Molecular Epidemiology, and Impact on Global Health Srinivas Reddy Pallerla, Dominik Harms, Reimar Johne, Daniel Todt, Eike Steinmann, Mathias Schemmerer, Jürgen J. Wenzel, Jörg Hofmann, James Wai Kuo Shih, Heiner Wedemeyer, C.-Thomas Bock, Thirumalaisamy P. Velavan Pathogens.2020; 9(10): 856. CrossRef
Hepatitis E Virus Drug Development Volker Kinast, Thomas L Burkard, Daniel Todt, Eike Steinmann Viruses.2019; 11(6): 485. CrossRef
Ha, Sang Deuk , Kim, Ji Ha , Park, Hey Lyoun , Hyun, Hyung Hwan , Chung, Hyung Min , Kim Kwon, Yun Hee , Seo, Seong Yum , Ko, Jung Jae , Lee, Hyun Hwan
Human protease inhibitor nexin-I(NX-I) cDNA(1.2Kb) was isolated from human lung cDNA library and expressed under the control of T7 promoter as a fused protein in Escherichia coli BL21 and E. coli GJ1158 by addition of IPTG and Nacl as inducers. For GJ1158, 300 mM NaCl was added for induction after the cell reached A_600=0.6. As a result, E. coli GJ1158 showed higher expression level than BL2l with lesser extent of inclusion bodies. The optimum concentration of NaCl exerting no induction effect but shortening the time to reach A_600=0.6 was 50 mM. All the results suggested that E. coli GJ1158 was a useful host for efficient expression of NX-I using NaCl as an inducer. The expressed NX-1 showed an inhibitory effect on thrombin activity. The expressed protein was purified by immobilized metal affinity column chromatography (IMAC) and characterized by digestion with enterokinase (EK).